NSE: JYOTHYLAB | BSE: 532926

Expensive Underperformer

Download real time

347.80 -0.70 (-0.20%)

41.63% Fall from 52W High

332.8K NSE+BSE Volume

NSE 19 May, 2025 2:58 PM (IST)

12,771.7

Market Cap

Below industry Median

0.5

Beta 1Year

Very Low volatility

Jyothy Labs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for JYOTHYLAB, BSE:532926 Jyothy Labs Ltd.

Jyothy Labs Ltd.

23 Jul 2019

347.80

-0.20%

Meager sales growth takes sheen off strong margin performance

Neutral: Jyothy Labs Ltd.

Target

Motilal Oswal

23 July 2019 Fabric care, Dishwashing and Personal care sales grew 5.4%, 1.1% and 13.3%, respectively, while Household Insecticides (HI) sales were down 21.6% YoY. Higher ad spends (+30bp YoY to 8.1% of sales) and staff cost (+40bp YoY to 12.2%) were offset by lower other expenses (-140bp YoY to 11.5%). Consequently, EBITDA margin expanded (1) Management expects a stable demand environment. However, competition is likely to remain intense in a deflationary commodity environment. (2) At end-FY19, management had guided for 12% top-line growth in FY20. This guidance has now been revised to 10-12%.

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

24 Jun 2019

347.80

-0.20%

Jyothy Labs

Hold: Jyothy Labs Ltd.

Sharekhan

We met Mr. Sanjay Agarwal, CFO, Jyothy Laboratories Limited (JLL) to understand the current demand environment and the company's plan of action to revive growth in key categories such as household insecticide (HI) and fabric care. We expect JLL's consolidated revenue to grow by about 10% (management has guided for 12-14% growth) and OPM to stand at ~15% in FY2020. Dishwashing (Pril and Exo), premium detergent (Henko) and personal wash (Margo) will continue to post double-digit growth. Ujala Fabric whitener is expected to grow in single...

Motilal Oswal decreased Neutral price target of Jyothy Labs Ltd. to 375.0 on 12 May, 2025.

Jyothy Labs Ltd.

30 May 2019

347.80

-0.20%

Jyothy Laboratories Ltd. - Result Update - 30 May 2019

Results Update: Jyothy Labs Ltd.

Way2Wealth

Gross margin contracted by 220 bps Y-O-Y led by input cost pressure. EBIDTA decreased by 6% Y-O-Y to `82.6 crs in the quarter. On EBIDTA margins front, there was 210 bps contraction largely led by employees and advertisement expenses....

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

09 May 2019

347.80

-0.20%

Jyothy Laboratories

Buy: Jyothy Labs Ltd.

Target

ICICI Securities Limited

Premiumisation and naturals' portfolio to boost revenue growth Exo and Pril brands under dishwashing segment delivered superior revenue growth in Q4FY19 and FY19 as JLL has been sharpening its focus towards premiumisation. Simultaneously, the company is promoting its naturals' brand Margo under personal care category (11% of sales) as the company is seeing significant scope for expanding the basket. Through its brands Margo, Fa and Neem toothpaste, JLL has a substantial presence in the naturals' category in a few southern states and West Bengal. Growing trend...

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

08 May 2019

347.80

-0.20%

JYOTHY LABORATORIES LIMITED

Accumulate: Jyothy Labs Ltd.

Target

Geojit BNP Paribas

Jyothy Laboratories Ltd (JLL) is an Indian FMCG player with products across Fabric care, Dishwashing, Mosquito repellents & Personal Care. JYL's revenue grew by 6.3%YoY for Q4FY19. For FY19, the growth was at 8.4%YoY, impacted by adverse seasonality in insecticide and flood impact in Kerala (Rs25-30cr). EBITDA margin declined by 210bps to 16.4% on account of 220bps reduction in gross margin. Despite reduction in margins, Q4FY19 PAT grew by 11%YoY. For...

Number of FII/FPI investors decreased from 224 to 215 in Mar 2025 qtr

Jyothy Labs Ltd.

07 May 2019

347.80

-0.20%

Jyothy Labs

Hold: Jyothy Labs Ltd.

Sharekhan

Limited (JLL) grew by 6.3% y-o-y to Rs. 504.3 crore in Q4FY2019 as against Rs. 474.5 crore in Q4FY2018. The single-digit revenue growth was largely volume-led during the quarter. The gross margins declined by 218 BPS largely on account of higher promotional activities. The operating profit decreased by 6% to Rs. 82.6 crore due to higher advertisement and employee expenses...

Motilal Oswal decreased Neutral price target of Jyothy Labs Ltd. to 375.0 on 12 May, 2025.

Jyothy Labs Ltd.

07 May 2019

347.80

-0.20%

Operating performance again misses estimates; remain Neutral

Neutral: Jyothy Labs Ltd.

Target

Motilal Oswal

7 May 2019 to INR5b (v/s est. EBITDA declined 6% YoY to INR826m (v/s est. Adj. PAT grew 11.1% YoY to INR670m (v/s our est. of INR605m) as 4Q19 saw deferred tax gain of INR110.3m v/s INR82.5m loss in the base quarter. Fabric care, Dishwashing and Personal care sales grew 2.2%, 21.6% and 2.8%, while Household Insecticides (HI) sales were down 4.

Motilal Oswal decreased Neutral price target of Jyothy Labs Ltd. to 375.0 on 12 May, 2025.

Jyothy Labs Ltd.

28 Jan 2019

347.80

-0.20%

Jyothy Laboratories Ltd.- Result Update - 28 January 2019

Results Update: Jyothy Labs Ltd.

Way2Wealth

Gross margin contracted by 60 bps Y-O-Y led by input cost pressure. EBIDTA grew by 5.2% Y-O-Y to `71.8crs in the quarter. On EBIDTA margins front, there was only 20 bps contraction largely led by lower advertisement expenses. EBIDTA for 9MFY19 grew by 16.7% Y-O-Y to `205.9crs with corresponding EBIDTA margin of 16.2%...

Motilal Oswal decreased Neutral price target of Jyothy Labs Ltd. to 375.0 on 12 May, 2025.

Jyothy Labs Ltd.

25 Jan 2019

347.80

-0.20%

Jyothy Laboratories

Buy: Jyothy Labs Ltd.

ICICI Securities Limited

Jyothy Labs (JLL) witnessed revenue growth of 6.3% to | 434.3 crore on the back of 6.1% overall volume growth. The company has taken price increase only in detergent category to the tune of 3%, which translates in less than 1% realisation growth for JLL Power brands Exo, Maxo, Henko & Pril saw strong growth of 7.6%, 10.5%, 17% & 12.1%, respectively. However, Margo brand declined 8.1% whereas Ujala witnessed muted growth of 1.9% EBITDA margins were flat in Q3FY19 (down 16 bps to 16.5%)...

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

24 Jan 2019

347.80

-0.20%

Growth still elusive; rich valuations capping upside potential

Neutral: Jyothy Labs Ltd.

Motilal Oswal

24 January 2019 INR4.7b) in 3QFY19, led by volume growth of 6.1% YoY. (16.7% v/s 22.7% in the year-ago period). Staff cost increased marginally by 10bp YoY to 10.6% of sales, while other expenses were flat at 14% of sales. Lower ad spends (-60bp YoY to 5.5% of sales), thus, restricted EBITDA margin contraction to 20bp YoY (16.5% v/s our estimate of 17%).

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Is Jyothy Labs Ltd. worth buying?

280 Votes:

Buy 80.71%

Sell 11.43%

Hold 7.86%

RESEARCH REPORTS

Neutral SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf